A 2021 meta-analysis involving 1870 patients has shown that H. pylori infection was associated with tumor PD-L1 expression, suggesting that H. pylori infection may be a predictor of a favorable response to immunotherapy in GC (44). This evidence concerns the gene CD274 and gastric cancer.